Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04897711 · ClinicalTrials.gov registry record · NA
Perceptual Training to Improve Listeners' Ability to Understand Speech Produced by Individuals With Dysarthria
A NA study of Dysarthria and Intelligibility, Speech, sponsored by Utah State University.
- Completed
- Registry status
- NA
- Development phase
- 217
- Enrollment target
- 2
- Study locations
NCT04897711: Completed NA study of Dysarthria and Intelligibility, Speech, sponsored by Utah State University.
NCT04897711 is a NA study of Dysarthria and Intelligibility, Speech that has completed, run by Utah State University. The registered enrollment target is 217 participants, above the 111-participant average among 7 other Dysarthria trials with a reported enrollment target (95% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04897711, a NA study of Dysarthria and Intelligibility, Speech, has completed, sponsored by Utah State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 217 participants
- Enrollment target
- 2
- Study locations
Study Summary
There exist very few effective treatments that ease the intelligibility burden of dysarthria. Perceptual training offers a promising avenue for improving intelligibility of dysarthric speech by offsetting the communicative burden from the speaker with dysarthria on to their primary communication partners-family, friends, and caregivers. This project, utilizing advanced explanatory models, will permit identification of speaker and listener parameters, and their interactions, that allow perceptual training paradigms to be optimized for intelligibility outcomes in dysarthria rehabilitation. This work addresses this critical gap in clinical practice and sets the stage for extension of dysarthria management to listener-targeted remediation-advancing clinical practice and enhanced communication and quality of life outcomes for this population.
Primary Outcome
A percentage words correct (PWC) score is tabulated for each listener at pretest. A higher score reflects greater speaker intelligibility (i.e., understanding).
Conditions Studied
Interventions
- BEHAVIORAL Perceptual Training
Study Locations (2)
Florida
- Florida State University - Tallahassee
Utah
- Utah State University - Logan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2021-04-26 |
| Est. Completion | 2023-07-01 |
| Phase | NA |
What the finished NCT04897711 record still lists
NCT04897711 is an interventional study that assigns participants to a tested intervention. The registered 217 participants enrollment target is mid-sized for trials with a published cap, above the 111-participant average among 7 other Dysarthria trials with a reported enrollment target (95% higher).
The record links to 2 conditions, with Dysarthria appearing as the primary indexed condition, and to 1 intervention - of which Perceptual Training is the first listed.
NCT04897711 reports a single indexed study location in Florida, Utah.
Frequently Asked Questions
What is clinical trial NCT04897711 about?
NCT04897711 is a clinical study titled "Perceptual Training to Improve Listeners' Ability to Understand Speech Produced by Individuals With Dysarthria". There exist very few effective treatments that ease the intelligibility burden of dysarthria. Perceptual training offers a promising avenue for improving intelligibility of dysarthric speech by offsetting the communicative burden from the speaker with dysarthria on to their primary communication par...
What is the current status of trial NCT04897711?
This trial is currently completed. It is a NA study. The enrollment target is 217 participants. The study started on 2021-04-26. Estimated completion is 2023-07-01.
What conditions does trial NCT04897711 study?
This clinical trial studies the following conditions: Dysarthria, Intelligibility, Speech.
What interventions are being tested in trial NCT04897711?
The interventions under investigation include: Perceptual Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT04897711?
This trial is sponsored by Utah State University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04897711 being conducted?
This trial has 2 study locations across Florida, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dysarthria
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Dysarthria Management for Minor Groups
RECRUITING · NA
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
RECRUITING · NA
-
Speech and Arm Combined Exergame
RECRUITING · NA
-
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
RECRUITING · NA
-
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05079282 · 217 participants · Phase 1
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
- NCT05470439 · 217 participants · NA
My Interprofessional Care Team for Adherence and Research Engagement Disparities
- NCT05981703 · 217 participants · Phase 1
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
- NCT06342258 · 217 participants · Phase 1
COES: Curing Order Effects on Sealants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI